FDA Warnings for Asian Patients

[alivenwell]

There is a link just issued today that has some warnings specifically directed towards Asian, Indian and Indonesian people for some epilepsy drugs.

Here's a link:
http://www.fda.gov/cder/drug/infopag...in/default.htm

FDA ALERT [11/24/2008] - FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen (HLA) allele, HLA-B*1502. This allele occurs almost exclusively in patients with ancestry across broad areas of Asia, including Han Chinese, Filipinos, Malaysians, South Asian Indians, and Thais. Because fosphenytoin is a prodrug and is converted to phenytoin after administration, any concern regarding this association is also applicable to fosphenytoin. Phenytoin and fosphenytoin are used to control tonic-clonic (grand mal) and complex-partial seizures in epilepsy.

A recent FDA Information for Healthcare Professionals sheet (12/12/2007), described an increased risk of SJS/TEN with another antiepileptic drug, carbamazepine, in Asian ancestry patients with the HLA-B*1502 allele.

The FDA is working to identify additional information to evaluate the possible risk of SJS/TEN from phenytoin and fosphenytoin in patients with HLA-B*1502. Until the evaluation is completed, healthcare providers who are considering the use of phenytoin or fosphenytoin should be aware of the risks and benefits described in the current prescribing information for this drug.

Because this new data suggests a possible association between HLA-B*1502 and phenytoin or fosphenytoin-induced SJS/TEN, and because of the known association between phenytoin and SJS/TEN, healthcare providers should consider avoiding phenytoin and fosphenytoin as alternatives for carbamazepine in patients who test positive for HLA-B*1502.

Healthcare Professional Information
Information for Healthcare Professionals
Labeling and Regulatory History of Phenytoin from Drugs@FDA
Labeling and Regulatory History of Fosphenytoin from Drugs@FDA
Other Information

Phenytoin is marketed under these names:


Dilantin


Phenytek

Fosphenytoin is marketed under these names:


Cerebyx

[hawke86]

Interesting article.

[skillefer]

That's assuming they test us for HLA-B1502. I don't think anyone has ever ordered that particular test for me.